Komori
Aigan (9854) · InitiativeAchieved

Dissolution and Liquidation of 北京愛眼眼鏡有限公司

First written in FY2023-Q3. 3 of 6 entries say "Restated". Latest entry: FY2025-H1.

6entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023-Q3RestatedFY2024-Q1 – FY20242023: 320232024: 32024
Same theme, other companies
Dissolution and Liquidation Proceedings for a Consolidated SubsidiaryA theme 88 companies write about · 27 as a headwind · 7 as a tailwind

The whole theme swung hardest in 2024: 2 of 14 companies on the "Worse" side.

41 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 88 companies compared. The sentences above are computed from all 88.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1AchievedAnnual report

    「Based on a resolution of the Board of Directors meeting held on 28 November 2022, our consolidated subsidiary Beijing Aigan Optical Co., Ltd. had been proceeding with various procedures for dissolution and liquidation in accordance with local laws and regulations, and the liquidation was completed on 20 August 2024.」

    The dissolution and liquidation of the Beijing subsidiary, resolved on 28 November 2022, reached completion on 20 August 2024.
  2. FY2024RestatedAnnual report

    「Based on a resolution of the Board of Directors at its meeting held on 28 November 2022, our consolidated subsidiary 北京愛眼眼鏡有限公司 (Beijing eyewear company) is currently carrying out the necessary procedures for dissolution and liquidation in accordance with applicable local laws and regulations. The final completion date of the liquidation has not yet been determined.」

    The dissolution and liquidation procedures for the Beijing subsidiary are ongoing, but the final completion date of the liquidation remains undetermined.
  3. FY2024-Q3RestatedAnnual report

    「Based on a resolution adopted at a meeting of the Board of Directors held on 28 November 2022, our consolidated subsidiary 北京愛眼眼鏡有限公司 is currently proceeding with the necessary procedures for dissolution and liquidation in accordance with local laws and regulations. The final completion date of the liquidation has not yet been determined.」

    The dissolution and liquidation procedures for the Beijing subsidiary are ongoing, but the final completion date of the liquidation remains undetermined.
  4. FY2024-Q1RestatedAnnual report

    「Based on a resolution adopted at a meeting of the Board of Directors held on 28 November 2022, our consolidated subsidiary 北京愛眼眼鏡有限公司 is currently proceeding with the necessary procedures for dissolution and liquidation in accordance with local laws and regulations. The final completion date of the liquidation has not yet been determined.」

    The dissolution and liquidation procedures for the Beijing subsidiary are ongoing, but the final completion date of the liquidation remains undetermined.
  5. FY2023AdvancedAnnual report

    「All 3 directly operated stores were closed by the end of last year. We will proceed with the necessary dissolution and liquidation procedures in accordance with local laws and regulations. The final completion date of the liquidation has not yet been determined.」

    Following the resolution to dissolve and liquidate the Beijing subsidiary, all 3 directly operated stores were closed by the end of 2022, and a ¥115 million loss on liquidation of a subsidiary was recorded. The liquidation procedures themselves are ongoing, and the completion date has not been determined.
  6. FY2023-Q3First statedAnnual report

    「At a meeting of the Board of Directors held on 28 November 2022, we resolved to dissolve and liquidate our consolidated subsidiary 北京愛眼眼鏡有限公司. We will proceed with the necessary dissolution and liquidation procedures in accordance with local laws and regulations. We decided to dissolve and liquidate 北京愛眼眼鏡有限公司 because we determined that a return to profitability had become extremely difficult, given its loss-making trend over the past several periods and the deterioration in performance resulting from the COVID-19 pandemic. We expect to record an approximately ¥110 million loss on liquidation of a subsidiary as an extraordinary loss during the current consolidated fiscal year.」

    The company resolved at a meeting of the Board of Directors held on 28 November 2022 to dissolve and liquidate its consolidated subsidiary responsible for the China business, citing its persistent losses and deterioration in performance due to COVID-19. Procedures under local laws and regulations are under way, and an approximately ¥110 million loss on liquidation is expected to be recorded during the current consolidated fiscal year.
Moved together

"Review of the Store Network through Store Openings, Closures and Renovations" moved the same way as this thread, in the same document, in 2 of its 6 moves.

2★1
  1. ★This thread
  2. 1Review of the Store Network through Store Openings, Closures and Renovations2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Aigan's next results are scheduled for 2026-11-10. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.